All Practice Exams

100+ Free ENADE Farmácia Practice Questions

Prepare for the ENADE Farmácia — Exame Nacional de Desempenho dos Estudantes exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

2026 Statistics

Key Facts: ENADE Farmácia Exam

Examination Administrator

Governing Federal Law

Official Examination Structure

Evaluation Rating Scale

Registration Fee

Target Population

Evaluation Cycle

Metadata Status

ENADE Farmácia is Brazil's mandatory national capstone assessment for graduating pharmacy undergraduates, evaluating SUS healthcare policies, pharmacology, pharmaceutics, medicinal chemistry, clinical care, laboratory analysis, and GMP quality assurance.

Sample ENADE Farmácia Practice Questions

Try these sample questions to test your ENADE Farmácia exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Under the Organic Health Law of Brazil (Lei nº 8.080/1990), which doctrinal principle of the Unified Health System (Sistema Único de Saúde - SUS) guarantees that every citizen has equal access to healthcare actions and services at all levels of complexity without prejudice or privileges of any kind?
A.Universalidade (Universality)
B.Descentralização político-administrativa (Political-administrative decentralization)
C.Participação da comunidade (Community participation)
D.Regionalização e hierarquização (Regionalization and hierarchy)
Explanation: Universalidade is a foundational doctrinal principle of the SUS established by the Federal Constitution of 1988 (Article 196) and regulated by Lei nº 8.080/1990. It guarantees health as a fundamental human right and a duty of the State, ensuring that all individuals have full access to health services and pharmaceutical assistance without discrimination. The other listed concepts represent organizational guidelines rather than the doctrinal principle of equal universal access.
2Federal Law nº 8.142/1990 regulates community participation (controle social) and intergovernmental financial transfers in the SUS. Regarding the composition and operation of Municipal Health Councils (Conselhos Municipais de Saúde), which rule is legally mandatory?
A.Representatives of healthcare professional associations must comprise at least 50% of the total council voting seats.
B.Representatives of healthcare users (usuários do SUS) must have parity representation, comprising 50% of all voting council seats.
C.Municipal Health Councils are purely consultative entities without authority over municipal health fund budget allocation.
D.Council members are appointed directly by the Municipal Health Secretary without election from civil society organizations.
Explanation: Lei nº 8.142/1990 and National Health Council Resolution (Resolução CNS nº 453/2012) mandate that Health Councils (Conselhos de Saúde) must have parity composition (composição paritária): 50% user representatives (usuários), 25% health workers/professionals, and 25% government representatives and private contracted/philanthropic providers. Health Councils are permanent and deliberative (deliberativos), meaning they formulate strategies and supervise the execution of health policy, including economic and financial aspects.
3The National Pharmaceutical Services Policy (Política Nacional de Assistência Farmacêutica - PNAF), approved by National Health Council Resolution nº 338/2004, redefined Pharmaceutical Care in Brazil. What is the fundamental concept of Assistência Farmacêutica under PNAF?
A.A commercial logistics process focused exclusively on centralized procurement and warehouse distribution of generic drugs.
B.A set of activities restricted to dispensing medications in retail private pharmacies under municipal sanitary surveillance.
C.A comprehensive, intersectoral health policy focused on promoting rational drug use, integrating logistics with patient-centered clinical care.
D.A program dedicated exclusively to funding high-cost biotechnology therapies for hospitalized intensive care patients.
Explanation: Resolução CNS nº 338/2004 defines Assistência Farmacêutica as an essential component of public health policy comprising a set of interrelated actions aimed at promoting, protecting, and recovering health through the universal and equitable access to medicines and their rational use. It integrates technical-logistical stages (selection, programming, procurement, distribution) with clinical and humanized pharmaceutical care across all SUS care levels.
4Financing and management of the National List of Essential Medicines (RENAME) in the SUS are organized into three distinct funding components. Which operational description correctly matches the Specialized Component of Pharmaceutical Services (Componente Especializado da Assistência Farmacêutica - CEAF)?
A.It provides first-line treatments for common acute and chronic diseases in Primary Health Care (Atenção Básica) funded mainly by municipal resources.
B.It provides drugs for national strategic endemic disease control programs, such as tuberculosis, leprosy (hanseníase), and malaria, funded directly by the Ministry of Health.
C.It provides high-cost, complex medications for chronic, rare, or refractory diseases, guided by Clinical Protocols and Therapeutic Guidelines (PCDT).
D.It provides subsidized over-the-counter phytotherapeutics through commercial agreements with private community pharmacies.
Explanation: The Componente Especializado da Assistência Farmacêutica (CEAF) provides access to high-cost medications for rare, severe, or refractory chronic conditions. Access is strictly regulated by Clinical Protocols and Therapeutic Guidelines (Protocolos Clínicos e Diretrizes Terapêuticas - PCDT) issued by the Ministry of Health, with financing shared between federal and state governments across Groups 1A, 1B, and 2.
5The National List of Essential Medicines (Relação Nacional de Medicamentos Essenciais - RENAME) serves as the guiding instrument for drug selection, procurement, and prescription in the SUS. What is the primary technical criterion used by CONITEC to recommend the inclusion of a new medicine in RENAME?
A.Commercial market popularity and highest sales volume in private retail pharmacies.
B.Scientific evidence of efficacy, safety, cost-effectiveness, and favorable budgetary impact compared to existing therapeutic alternatives.
C.Filing of a patent application with the Brazilian National Institute of Industrial Property (INPI).
D.Direct unilateral requisition by pharmaceutical manufacturing labor unions.
Explanation: Under Lei Federal nº 12.401/2011 and Decree nº 7.508/2011, the National Committee for Health Technology Incorporation (CONITEC) evaluates scientific evidence using Health Technology Assessment (Avaliação de Tecnologias em Saúde - ATS). Decisions require robust evidence of clinical efficacy, comparative safety, cost-effectiveness, and budgetary impact on the SUS relative to existing therapeutic options.
6The Programa Farmácia Popular do Brasil (PFPB) is a federal partnership initiative that expands access to essential medicines through accredited community pharmacies. For which clinical conditions does the 'Saúde Não Tem Preço' axis provide 100% free (gratuito) subsidized medication to all Brazilian citizens?
A.Severe cancer chemotherapy, end-stage kidney failure, and organ transplantation.
B.Hypertension (Hipertensão Arterial), Diabetes Mellitus, and Asthma (Asma).
C.Major depressive disorder, schizophrenia, and epilepsy.
D.Acute bacterial meningitis, deep vein thrombosis, and tuberculosis.
Explanation: Under the 'Saúde Não Tem Preço' initiative of the Programa Farmácia Popular do Brasil, the Brazilian Ministry of Health provides 100% free access to medicines used for Hypertension (e.g., losartan, enalapril, hydrochlorothiazide), Diabetes Mellitus (e.g., metformin, glibenclamide, NPH/regular insulins), and Asthma (e.g., salbutamol, beclomethasone), as well as osteoporosis and maternal contraceptives under updated expansions.
7Federal Law nº 13.021/2014 represented a historic milestone for Brazilian pharmacy by redefining the legal nature of pharmaceutical establishments. According to this law, how are pharmacies categorized, and what is the technical staffing requirement?
A.Purely commercial establishments where pharmacist presence is optional during off-peak and weekend retail hours.
B.Units of health assistance provision (unidades de prestação de assistência à saúde), requiring the mandatory physical presence of a registered pharmacist during 100% of operating hours.
C.Sanitary storage warehouses requiring a registered pharmacist solely for quarterly controlled substance logbook audits.
D.Auxiliary medical clinics where the pharmacist must be directly supervised by a licensed physician.
Explanation: Lei Federal nº 13.021/2014 legally reclassified pharmacies and drugstores (drogarias) from commercial establishments into health facilities (unidades de prestação de serviços de assistência farmacêutica, assistência à saúde e orientação sanitária). The law mandates the mandatory physical presence of a qualified, registered pharmacist (farmacêutico responsável técnico ou substituto) during the entire operating schedule (todo o horário de funcionamento).
8Federal Council of Pharmacy Resolutions (Resoluções CFF nº 585/2013 and nº 586/2013) established the clinical competencies and prescribing authority of Brazilian pharmacists. Under which condition is a pharmacist legally authorized to prescribe non-prescription medications (MIPs) and prescription-only medications?
A.Pharmacists may prescribe over-the-counter drugs (MIPs) autonomously, and prescription-only drugs when conditioned on institutional collaborative protocols or clinical guidelines approved in healthcare settings.
B.Pharmacists may independently prescribe all classes of medications, including controlled psychotropics and antimicrobials, without any medical collaboration.
C.Pharmacists are strictly prohibited from prescribing any substance, including dietary supplements and dermocosmetics.
D.Pharmacists may prescribe prescription-only drugs exclusively in private cosmetic clinics for aesthetic procedures.
Explanation: Resolução CFF nº 586/2013 authorizes pharmacists to autonomously prescribe non-prescription medications (Medicamentos Isentos de Prescrição - MIPs), herbal products, and nutritional supplements based on clinical assessment. To prescribe prescription-only medications (medicamentos sob prescrição médica), the pharmacist must act within established collaborative clinical protocols, clinical guidelines, or multi-professional programs officially approved by the health institution.
9Portaria SVS/MS nº 344/1998 regulates substances subject to special control in Brazil. A patient presents a blue prescription form (Notificação de Receita 'B') for Clonazepam 2 mg tablets. What are the legal validity period and maximum treatment duration allowed for this prescription?
A.Validity of 10 days from issuance, maximum duration of 30 days of treatment.
B.Validity of 30 days from issuance within the issuing federative unit (UF), maximum duration of 60 days of treatment.
C.Validity of 15 days from issuance nationwide, maximum duration of 180 days of treatment.
D.Validity of 60 days from issuance, maximum duration of 365 days of treatment.
Explanation: Under Portaria SVS/MS nº 344/1998, a Notificação de Receita 'B' (blue form, used for psychotropic substances of List B1, such as benzodiazepines) is valid for 30 consecutive days from the date of issuance in the issuing state (UF) and allows dispensing for a maximum treatment duration of 60 days (or up to 5 ampoules for injectables).
10Under ANVISA regulations on antimicrobial dispensing (RDC nº 20/2011 and RDC nº 471/2021), what are the legal requirements regarding prescription validity and documentation retention in community pharmacies?
A.Prescriptions are valid for 10 days from issuance; the pharmacy retains the 2nd copy (2ª via) and records the transaction in SNGPC.
B.Prescriptions are valid for 30 days from issuance; the pharmacy returns all copies to the patient after inspection.
C.Prescriptions are valid for 5 days; the pharmacy must keep the original 1st copy and forward a copy to the federal police.
D.Prescriptions are valid indefinitely until all refills are completed without mandatory retention.
Explanation: ANVISA RDC nº 20/2011 and RDC nº 471/2021 mandate that medical/dental prescriptions for systemic antimicrobials are valid for exactly 10 days throughout the national territory starting from the day following issuance. The dispensing establishment must retain the second copy (2ª via - retenção da farmácia/drogaria), return the stamped first copy to the patient, and record inventory movements in the National Controlled Products Management System (SNGPC).

About the ENADE Farmácia Exam

The Exame Nacional de Desempenho dos Estudantes (ENADE) for Pharmacy (Farmácia) is the official national capstone examination established under Brazil's National Higher Education Evaluation System (SINAES, Lei Federal nº 10.861/2004) and administered by INEP under the Ministry of Education (MEC). Designed to assess graduating seniors (concluintes) in Pharmacy, ENADE evaluates mastery of pharmaceutical sciences, clinical drug therapy, pharmaceutical technology, laboratory diagnostic analysis, and Brazilian public healthcare policies aligned with the National Curriculum Guidelines (Diretrizes Curriculares Nacionais - DCNs de Farmácia), the Federal Council of Pharmacy (Conselho Federal de Farmácia - CFF), and the National Health Surveillance Agency (ANVISA). The examination tests students across both General Education (Formação Geral) and Specific Pharmacy Components (Componente Específico). This question bank provides an English-language multiple-choice study adaptation covering public health (SUS & Assistência Farmacêutica), clinical and basic pharmacology, pharmaceutics and industrial technology, medicinal chemistry and pharmacognosy, pharmaceutical care and clinical pharmacy, clinical pathology and toxicology, and quality assurance and hospital pharmacy logistics.

Assessment

4-hour written examination made up of 10 Formação Geral items, common to every area and weighted at 25% of the mark, and 30 Componente Específico items weighted at 75%. Both components combine multiple-choice and discursive items built on situações-problema and case studies; the precise objective/discursive split is set by the Inep edital for each edition, and the Formação Geral component follows the diretrizes in Portaria MEC nº 154/2026 from the 2026 edition onwards. Our practice bank is MCQ-only study support and does not reproduce the discursive items.

Time Limit

4 hours

Passing Score

Conceito Enade (1 to 5)

Exam Fee

Free (mandatory national assessment) (INEP — Ministério da Educação)

ENADE Farmácia Exam Content Outline

15%

Formação Geral, Políticas de Saúde e Assistência Farmacêutica no SUS

Legislative and structural foundations of healthcare in Brazil: Unified Health System principles (Universalidade, Integralidade, Equidade, Descentralização, Participação Social under Lei nº 8.080/1990 and Lei nº 8.142/1990), National Medicines Policy (PNM - Portaria nº 3.916/1998), National Pharmaceutical Services Policy (PNAF - Resolução CNS nº 338/2004), the Pharmaceutical Services Cycle (selection, programming, acquisition, storage, distribution, dispensing), RENAME financing tiers (Componente Básico, Estratégico, Especializado), Farmácia Popular, Lei nº 13.021/2014 (pharmacy as a healthcare establishment), CFF ethical and clinical regulations (Resoluções nº 724/2022, 585/2013, 586/2013), and controlled substance dispensing under Portaria SVS/MS nº 344/1998.

20%

Farmacologia Básica, Clínica e Terapêutica

Comprehensive study of drug mechanisms and clinical therapeutics: quantitative pharmacokinetics (absorption, distribution, protein binding, volume of distribution, systemic clearance, half-life, steady-state kinetics, non-linear Michaelis-Menten elimination), pharmacodynamics (receptor superfamilies, second messengers, agonists, competitive and non-competitive antagonists, allosteric modulators, therapeutic index), Cytochrome P450 (CYP3A4, CYP2D6, CYP2C9, CYP2C19, CYP1A2) metabolism and drug interactions, cardiovascular pharmacology (antihypertensives, antiarrhythmics, heart failure drugs), autonomic pharmacology, central nervous system therapeutics, antimicrobials and resistance mechanisms (ESBL, MRSA, carbapenemases), antidiabetic and lipid-lowering therapies, antithrombotics, and toxicology of drug overdoses.

15%

Farmacotécnica, Tecnologia Farmacêutica e Cosmetologia

Physicochemical and industrial principles of dosage form design, manufacturing, and stabilization: solid dosage forms (tablets, compression physics, wet and dry granulation, direct compression, excipient functionality, coating technologies, hard/soft gelatin capsules), liquid disperse systems (suspensions, Stokes' law, sedimentation volume, flocculation, emulsions, HLB theory, physical stability), semi-solids (hydrogels, ointments, creams, rheological behavior), sterile injectables (cleanroom classification, water for injection systems, sterilization cycles, lyophilization/freeze-drying), Biopharmaceutics Classification System (BCS Classes I-IV), Good Compounding Practices (RDC ANVISA nº 67/2007), cosmetic formulations, and pharmaceutical stability testing under Zone IVb conditions.

15%

Química Farmacêutica, Farmacognosia e Fitoterapia

Chemical and natural product foundations of pharmacology: Structure-Activity Relationships (SAR), classical and non-classical bioisosterism, prodrug design strategies, physicochemical parameters (LogP, pKa, topological polar surface area, Lipinski's Rule of 5), Phase I (functionalization) and Phase II (conjugation) metabolic transformations, secondary plant metabolite classes (alkaloids, flavonoids, tannins, coumarins, cardiac glycosides, saponins, anthraquinones, essential oils), natural product extraction and isolation techniques (maceration, percolation, Soxhlet, supercritical CO2), botanical quality control and phytochemical screening according to the Farmacopeia Brasileira, and Brazilian phytotherapy regulations (RDC ANVISA nº 26/2014).

15%

Farmácia Clínica, Cuidado Farmacêutico e Farmacoterapia

Patient-centered clinical pharmacy practice: Pharmaceutical Care methodologies (Dader method, SOAP documentation, Pharmacist's Workup of Drug Therapy), identification, prevention, and resolution of Drug-Related Problems (DRPs / PRMs according to Strand, Minnesota, and Granada classifications), medication reconciliation across transitions of care, medication therapy management (MTM / GTM), polypharmacy management in older adults using Beers and STOPP/START criteria, evidence-based pharmacotherapy for major chronic conditions (arterial hypertension, type 2 diabetes mellitus, dyslipidemia, asthma, COPD, chronic kidney disease), therapeutic drug monitoring (TDM) for narrow therapeutic index medications, antimicrobial stewardship programs, and point-of-care clinical testing (TLR/TCC) in pharmacy settings under RDC ANVISA nº 786/2023.

10%

Análises Clínicas, Imunologia e Toxicologia

Laboratory medicine and toxicological evaluation: hematological diagnostics including complete blood count (erythrogram parameters: RBC, Hb, Hct, MCV, MCH, MCHC, RDW; differential diagnosis of microcytic/macrocytic anemias; leukogram differential counting, left shift, reactive lymphocytes; platelet assessment and coagulogram: PT/INR, aPTT), biochemical organ panels (renal function: serum creatinine, eGFR, clearance, BUN; liver function: transaminases AST/ALT, ALP, GGT, bilirubins; cardiac markers: high-sensitivity troponins, CK-MB; lipid panel; glycemic parameters), urinalysis (EAS physical, chemical, and microscopic sediment analysis), clinical microbiology (Gram staining, bacterial identification, EUCAST/BrCAST antibiogram interpretation), parasitology methods (Hoffman, Faust, Kato-Katz), toxidromes (anticholinergic, cholinergic, opioid, sympathomimetic), specific toxicological antidotes, and occupational biomonitoring under NR-7.

10%

Controle de Qualidade, Boas Práticas e Farmácia Hospitalar

Quality assurance systems and institutional pharmaceutical management: analytical method validation parameters under RDC ANVISA nº 166/2017 (specificity, linearity, precision, accuracy, LOD, LOQ, robustness), pharmacopeial quality control assays for finished pharmaceutical forms (dissolution testing, dissolution profiles, friability, hardness, disintegration, uniformity of dosage units), microbiological testing (TAMC, TYMC, sterility testing), bacterial endotoxin testing (LAL assay), Good Manufacturing Practices (GMP/BPF under RDC ANVISA nº 658/2019, CAPA, change control, validation), hospital pharmacy logistics (Pharmacy and Therapeutics Committee / CFT, standardized formularies, ABC and VEN classification curves, unit-dose drug distribution SDMUD, cleanroom compounding of Total Parenteral Nutrition / TPN and antineoplastics under RDC nº 220/2004), and pharmacovigilance causality assessment (Naranjo algorithm, VigiMed/NOTIVISA).

How to Pass the ENADE Farmácia Exam

What You Need to Know

  • Passing score: Conceito Enade (1 to 5)
  • Assessment: 4-hour written examination made up of 10 Formação Geral items, common to every area and weighted at 25% of the mark, and 30 Componente Específico items weighted at 75%. Both components combine multiple-choice and discursive items built on situações-problema and case studies; the precise objective/discursive split is set by the Inep edital for each edition, and the Formação Geral component follows the diretrizes in Portaria MEC nº 154/2026 from the 2026 edition onwards. Our practice bank is MCQ-only study support and does not reproduce the discursive items.
  • Time limit: 4 hours
  • Exam fee: Free (mandatory national assessment)

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

ENADE Farmácia Study Tips from Top Performers

1Integrate Public Health Legislation with Pharmacy Operations: Understand how Lei nº 8.080/1990 and Lei nº 8.142/1990 govern the SUS, how the Pharmaceutical Services Cycle operates across RENAME components (Básico, Estratégico, Especializado), and how Lei nº 13.021/2014 and CFF Resoluções nº 585/586 empower pharmacist-led clinical care.
2Master Pharmacokinetic Calculations & CYP450 Interactions: Practice calculating half-life (t1/2 = 0.693 × Vd / CL), steady-state concentration (Css = (F × Dose) / (CL × τ)), loading dose (LD = Vd × Target Css), and memorize clinically critical CYP450 inducers (rifampin, carbamazepine, phenytoin) and inhibitors (ketoconazole, fluoxetine, clarithromycin).
3Connect Industrial Pharmaceutics to Physicochemical Principles: Relate tablet defects (capping, lamination) to compression speed, excessive fines, and moisture; apply Stokes' law to suspension stability; and know cleanroom environmental classifications (Grade A laminar flow for aseptic filling vs Grade B-D backgrounds).
4Differentiate Laboratory Biomarkers & Hematology: Master the interpretation of MCV and RDW to differentiate iron deficiency anemia from thalassemia trait; recognize leukemoid reactions vs leukemias; interpret PT/INR (extrinsic pathway) vs aPTT (intrinsic pathway); and evaluate toxicological syndromes (cholinergic SLUDGE vs anticholinergic delirium).
5Apply Systematic Clinical Pharmacy Methods (SOAP & PRM/DRP): Practice classifying Drug-Related Problems (necessity, effectiveness, safety) and structuring interventions using the SOAP framework (Subjective, Objective, Assessment, Plan) for chronic comorbidities such as hypertension, type 2 diabetes, and dyslipidemia.

Frequently Asked Questions

What is ENADE Farmácia and who is required to take it?

ENADE Farmácia is Brazil's official national student performance examination for undergraduate Pharmacy programs (Bacharelado em Farmácia). It is administered cyclically by INEP under the Ministry of Education (MEC) within the SINAES framework (Lei nº 10.861/2004). Taking the examination and completing the Student Questionnaire is mandatory for graduating pharmacy seniors (concluintes) as a legal prerequisite for graduation (colação de grau) and professional diploma registration.

What is the official structure of the ENADE Farmácia examination?

The official ENADE Farmácia exam is a single 4-hour written test consisting of 40 questions: 10 General Training items (Formação Geral, worth 25% of the total score, comprising 8 multiple-choice and 2 discursive questions) and 30 Specific Component items (Componente Específico em Farmácia, worth 75% of the total score, comprising 27 multiple-choice and 3 discursive questions). This practice bank provides 100 comprehensive multiple-choice questions adapting the entire curriculum into an English-language study tool.

How is student performance scored and what is Conceito Enade?

Individual student scores are aggregated and standardized by INEP to calculate the Conceito Enade on a scale from 1 to 5 for each university pharmacy program. Scores 1 and 2 indicate unsatisfactory performance triggering MEC supervisory measures; score 3 represents the national benchmark standard; scores 4 and 5 represent high academic excellence. The Conceito Enade directly feeds into institutional indicators such as the CPC (Conceito Preliminar de Curso) and IGC (Índice Geral de Cursos).

Are students required to pay any fee to register for ENADE Farmácia?

No. The examination is 100% free of charge for students. It is fully funded by the Brazilian Federal Government through MEC/INEP. Higher education institutions are legally responsible for enrolling all eligible graduating students.

How does ENADE Farmácia connect with professional licensing through the CFF and CRF?

ENADE is an academic assessment of course quality conducted by MEC/INEP. Once a student successfully fulfills all curricular requirements (including ENADE attendance) and receives their Pharmacy degree from an accredited institution, they register with their regional Conselho Regional de Farmácia (CRF), governed by the Conselho Federal de Farmácia (CFF under Lei nº 3.820/1960). The CRF issues the professional license required to legally practice as a Pharmacist (Farmacêutico) across community, hospital, industrial, and clinical laboratory settings in Brazil.

What happens if an eligible graduating student fails to attend the ENADE exam?

A graduating student who fails to attend the examination is designated as 'irregular' under SINAES/MEC regulations. This status legally prevents the university from holding the graduation ceremony (colação de grau) and issuing the official diploma. The student must formally request dispensation via the INEP portal with valid documentation (e.g., medical emergency, official civic duty) during the designated window or wait for institutional regularização in the subsequent cycle.